These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 16325858)
1. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage. Georgiou L; Minopoulos G; Lirantzopoulos N; Fiska-Demetriou A; Maltezos E; Sivridis E J Surg Res; 2006 Mar; 131(1):118-23. PubMed ID: 16325858 [TBL] [Abstract][Full Text] [Related]
2. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables. Erdem O; Erdem M; Dursun A; Akyol G; Erdem A Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience. Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer. Han HS; Park YM; Hwang TS J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061 [TBL] [Abstract][Full Text] [Related]
7. Bio-pathological factors of prognostic value in colorectal adenocarcinomas. Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924 [TBL] [Abstract][Full Text] [Related]
8. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II. Xu F; Xu J; Lou Z; Di M; Wang F; Hu H; Lai M Am J Surg Pathol; 2009 Sep; 33(9):1287-92. PubMed ID: 19471152 [TBL] [Abstract][Full Text] [Related]
9. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
10. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268 [TBL] [Abstract][Full Text] [Related]
11. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer. Demirbaş S; Sücüllü I; Yildirim S; Celenk T Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach. Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women. Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671 [TBL] [Abstract][Full Text] [Related]
16. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228 [TBL] [Abstract][Full Text] [Related]
18. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer. Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242 [TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena. Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835 [TBL] [Abstract][Full Text] [Related]
20. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors? Zafirellis K; Karameris A; Milingos N; Androulakis G Anticancer Res; 2005; 25(5):3629-36. PubMed ID: 16101192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]